Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141875 |
| CAS No | NA |
| Mol.F. | C34H43N5O4 |
| Mol.Wt. | 585.7 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141876 |
| CAS No | NA |
| Mol.F. | C30H35N5O3 |
| Mol.Wt. | 513.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141877 |
| CAS No | NA |
| Mol.F. | C30H35N5O3 |
| Mol.Wt. | 513.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141878 |
| CAS No | NA |
| Mol.F. | C30H36N6O4 |
| Mol.Wt. | 544.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141879 |
| CAS No | NA |
| Mol.F. | C21H16IN3O2 |
| Mol.Wt. | 469.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141880 |
| CAS No | NA |
| Mol.F. | C12H13N5O2 |
| Mol.Wt. | 259.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141881 |
| CAS No | NA |
| Mol.F. | C24H28N4O3 |
| Mol.Wt. | 420.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141882 |
| CAS No | NA |
| Mol.F. | C12H23N3O4 |
| Mol.Wt. | 273.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141883 |
| CAS No | NA |
| Mol.F. | C11H21N3O4 |
| Mol.Wt. | 259.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141884 |
| CAS No | NA |
| Mol.F. | C5H3N5O2 |
| Mol.Wt. | 165.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141885 |
| CAS No | NA |
| Mol.F. | C13H18N2O2 |
| Mol.Wt. | 234.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141886 |
| CAS No | NA |
| Mol.F. | C22H18N4O3 |
| Mol.Wt. | 386.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141887 |
| CAS No | NA |
| Mol.F. | C22H16N4O5 |
| Mol.Wt. | 416.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141888 |
| CAS No | NA |
| Mol.F. | C23H20N4O3 |
| Mol.Wt. | 400.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141889 |
| CAS No | NA |
| Mol.F. | C27H23N5O6 |
| Mol.Wt. | 513.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141890 |
| CAS No | NA |
| Mol.F. | C21H16N4O3 |
| Mol.Wt. | 372.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |